Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: Newer treatment modalities

ONCOLOGY

Volumn 20, Issue 8, 2006, Pages 899-905

  Decker, Roy H ^a   Tanoue, Lynn T ^a   Colasanto, Joseph M ^a   Detterbeck, Frank C ^a   Wilson, Lynn D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; RADIOFREQUENCY ABLATION; REVIEW; CATHETER ABLATION; FEMALE; LUNG TUMOR; MALE; PATHOLOGY; RADIATION DOSE; RADIOSURGERY; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RADIATION DOSAGE; RADIOSURGERY; TREATMENT OUTCOME;

EID: 34250687405     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Timmerman RD, Forster KM, Chinsoo CL: Extracranial stereotactic radiation delivery. Semin Radiat Oncol 15:202-207, 2005.
2. Uematsu M, Shioda A, Suda A, et al: Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 51:666-670, 2001.
3. Nagata Y, Negoro Y, Aoki T, et al: Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52:1041-1046, 2002.
4. McGarry RC, Papiez L, Williams M, et al: Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 63:1010-1015, 2005.
5. Fukumoto S, Shirato H, Shimzu S, et al: Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer 95:1546-1553, 2002.
6. Zimmermann FB, Geinitz H, Schill S, et al: Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48:107-114, 2005.
7. Hiraoka M, Nagata Y: Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: The Japanese experience. Int J Clin Oncol 9:352-355, 2004.
8. Wulf J, Haedinger U, Oppitz U, et al: Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60:186-196, 2004.
9. Hof H, Herfarth KK, Munter M, et al: Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56:335-341, 2003.
10. Onishi H, Araki T, Shirato H, et al: Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101:1623-1631, 2004.
11. Giraud P, Yorke E, Ford EC, et al: Reduction of organ motion in lung tumors with respiratory gating. Lung Cancer 51:41-51, 2006.
12. Yorke E, Rosenzweig KE, Wagman R, et al: Interfractional anatomic variation in patients treated with respiration-gated radiotherapy. J Appl Clin Med Phys 6:19-32, 2005.
13. Shirato H, Seppenwoolde Y, Kitamura K, et al: Intrafractional tumor motion: lung and liver. Semin Radiat Oncol 14:10-18, 2004.
14. Ford EC, Mageras GS, Yorke E, et al: Respiration-correlated spiral CT: A method of measuring respiratory-induced anatomic motion for radiation treatment planning. Med Phys 30:88-97, 2003.
15. Lax I, Blomgren H, Naslund I, et al: Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33:677-683, 1994.
16. Balter JM, Dawson LA, Kazanjian S, et al: Determination of ventilatory liver movement via radiographic evaluation of diaphragm position. Int J Radiat Oncol Biol Phys 51:267-270, 2001.
17. Onishi H, Kuriyama K, Komiyama T, et al: A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices. Int J Radiat Oncol Biol Phys 56:14-20, 2003.
18. Shiu AS, Chang EL, Ye JS, et al: Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: An emerging paradigm for achieving true stereotaxy. Int J Radiat Oncol Biol Phys 57:605-613, 2003.
19. Timmerman R, Papiez L, McGarry R, et al: Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124:1946-1955, 2003.
20. Ohashi T, Takeda A, Shigematsu N, et al: Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors. Int J Radiat Oncol Biol Phys 62:1003-1008, 2005.
21. Uno T, Aruga T, Isobe K, et al: Radiation bronchitis in lung cancer patient treated with stereotactic radiation therapy. Radiat Med 21:228-231, 2003.
22. Miller KL, Shafman TD, Anscher MS, et al: Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 61:64-69, 2005.
23. Fernando HC, De HA, Landreneau RJ, et al: Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 129:639-644, 2005.
24. Gadaleta C, Catino A, Ranieri G, et al: Radiofrequency thermal ablation of 69 lung neoplasms. J Chemother 16(suppl 5):86-89, 2004.
25. Akeboshi M, Yamakado K, Nakatsuka A, et al: Percutaneous radiofrequency ablation of lung neoplasms: Initial therapeutic response. J Vasc Interv Radiol 15:463-470, 2004.
26. Lee JM, Jin GY, Goldberg SN, et al: Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: Preliminary report. Radiology 230:125-134, 2004.
27. Suh RD, Wallace AB, Sheehan RE, et al: Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - preliminary results. Radiology 229:821-829, 2003.
28. vanSonnenberg E, Shankar S, Morrison PR, et al: Radiofrequency ablation of thoracic lesions: Part 2, initial clinical experience - technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184:381-390, 2005.
29. Erdi YE, Macapinlac H, Rosenzweig KE, et al: Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 27:861-866, 2000.
30. Bojarski JD, Dupuy DE, Mayo-Smith WW: CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: Results in 32 tumors. AJR Am J Roentgenol 185:466-471, 2005.
31. Belfiore G, Moggio G, Tedeschi E, et al: CT-guided radiofrequency ablation: A potential complementary therapy for patients with unresectable primary lung cancer - a preliminary report of 33 patients. AJR Am J Roentgenol 183:1003-1011, 2004.
32. Fernando HC, Hoyos AD, Litle V, et al: Radiofrequency ablation: Identification of the ideal patient. Clin Lung Cancer 6:149-153, 2004.
33. Jain SK, Dupuy DE, Cardarelli GA, et al: Percutaneous radiofrequency ablation of pulmonary malignancies: Combined treatment with brachytherapy. AJR Am J Roentgenol 181:711-715, 2003.
34. Mathur PN, Edell E, Sutedja T, et al: Treatment of early stage non-small cell lung cancer. Chest 123:176S-180S, 2003.
35. Sutedja TG, van Boxem AJ, Postmus PE: The curative potential of intraluminal bronchoscopic treatment for early-stage non-small-cell lung cancer. Clin Lung Cancer 2:264-270, 2001.
36. Okunaka T, Kato H, Tsutsui H, et al: Photodynamic therapy for peripheral lung cancer. Lung Cancer 43:77-82, 2004.
37. Deygas N, Froudarakis M, Ozenne G, et al: Cryotherapy in early superficial bronchogenic carcinoma. Chest 120:26-31, 2001.
38. Freitag L, Ernst A, Thomas M, et al: Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 59:790-793, 2004.
39. Sanfilippo NJ, Hsi A, DeNittis AS, et al: Toxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract. Lasers Surg Med 28:278-281, 2001.
40. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004.
41. Strauss GM, Herndon J, Maddaus MA: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) protocol 9633 (abstract 7019). J Clin Oncol 22(14S):621s, 2004.
42. Winston TL, Livingston R, Johnson D: A prospective randomized trial of adjuvant vinorelbine and cisplatin in completely resected stage IB and II non small cell lung cancer (NSCLC): Intergroup JBR.10 (abstract 7018). J Clin Oncol 22(14S):621s, 2004.
43. Sedrakyan A, Van Der MJ, O'Byrne K, et al: Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 128:414-419, 2004.
44. Fry WA, Phillips JL, Menck HR: Ten-year survey of lung cancer treatment and survival in hospitals in the United States: A national cancer data base report. Cancer 86:1867-1876, 1999.